Marshall J Glesby

Associate Chief of the Division of Infectious Diseases · Weill Cornell Medical College, Cornell Univ

Credentials: · · · ·

History

Division of Infectious Diseases · Weill Cornell Medical College, Cornell Univ
Present
Clinical Trials Design and Analysis course · Weill Cornell K30 funded Masters in Clinical Investigation program
Present
Weill Cornell Medical College, Cornell Univ
Present

1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial
National Heart, Lung, and Blood Institute · UH3
PI · $5.5M · Weill Medical Coll of Cornell Univ
2021–2026
Clonal Hematopoeisis in HIV and Aging
National Institute on Aging · R21
Contact PI · $466.1K · Weill Medical Coll of Cornell Univ
2020–2024
1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial
National Heart, Lung, and Blood Institute · UG3
PI · $1.4M · Weill Medical Coll of Cornell Univ
2021–2022
Doxycycline for COPD in HIV-Infected Patients
National Heart, Lung, and Blood Institute · R34
PI · $1.1M · Weill Medical Coll of Cornell Univ
2012–2017

Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)
Principal investigator · Active not recruiting · Phase 2
Weill Medical College of Cornell University
2022–2027
Doxycycline for COPD in HIV-Infected Patients
Principal investigator · Completed
Weill Medical College of Cornell University
2014–2020
Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
Principal investigator · Completed · Phase 1, Phase 2
Weill Medical College of Cornell University
2005–2010
Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance
Study chair · Completed · Phase 2
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
2009–2011